TotalMarketCap

Biodexa Pharmaceuticals

BDRXNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.263 M

$2.41 -10.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Biodexa Pharmaceuticals (BDRX) has a market capitalization of $1.26M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

225,817,808,922

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #492Karyopharm TherapeuticsKPTI$1.40M
  2. #493PMGCELAB$1.32M
  3. #494Biodexa PharmaceuticalsBDRX$1.26M
  4. #495Artelo BiosciencesARTL$1.16M
  5. #496Matinas BioPharmaMTNB$1.10M

What if Biodexa Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$53,862,511

Per share 22,349,590× higher

Bitcoin $1.53T

$2,914,407

Per share 1,209,297× higher

Apple $5.02T

$9,567,725

Per share 3,970,010× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Biodexa Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.